G92C (p.Gly92Cys) variant of KRT3 (Keratin, type II cytoskeletal 3)

G92C (p.Gly92Cys) in KRT3 (Keratin, type II cytoskeletal 3) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.34 / 1. The record also includes population frequency data and structural context.

G92C (p.Gly92Cys) variant details